Side-by-side comparison of AI visibility scores, market position, and capabilities
Modern mobile drug reference app for prescribers with dosing, interactions, and patient education; 50K+ healthcare providers from YC-backed competing with Epocrates for clinical decision support.
Pyrls is a Minneapolis-based healthcare technology company providing a modern medical drug reference app that enables clinicians, pharmacists, and healthcare trainees to prescribe medications, check interactions, and educate patients more effectively — delivering clinical decision support at the point of care through a mobile-first reference tool that competes with Epocrates as the go-to medication reference for healthcare providers. Founded in 2020 and backed by Y Combinator, Pyrls serves 50,000+ healthcare providers and trainees across hundreds of organizations, achieving $500,000 in revenue in 2024 with a 34-person team.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.